Table 2.

Unadjusted comparison of BP measurements and HTN indices.

	Time Period
Characteristic*	Period 1	Period 2	p-value for difference†
Patient Visits (N)	N=345	N=506
Casual SBP%ile	64 [34, 88]	54 [27, 79]	0.001
Casual DBP%ile	68 [40, 88]	59 [35, 84]	0.017
Casual BP Status			0.044
Normotensive	63% (216)	70% (353)
Uncontrolled pre-HTN	15% (53)	15% (74)
Uncontrolled HTN	22% (76)	16% (79)
SR-High BP diagnosis	56% (185)	57% (285)	0.83
Current antihypertensive use	71% (244)	65% (328)	0.075
Current ACE/ARB	59% (205)	56% (282)	0.29
ACE	56% (182)	54% (249)	0.51
ARB	13% (41)	12% (57)	0.91
Beta-Blocker	5% (16)	3% (15)	0.27
Alpha Blocker	1% (4)	2% (8)	0.77
Alpha/Beta Blocker	3% (10)	2% (10)	0.49
Calcium Channel Blocker	17% (54)	15% (70)	0.55
Centrally acting alpha-2 agonist	3% (10)	3% (13)	0.83
Direct vasodilator	<1% (3)	<1% (3)	0.69
Diuretic	10% (32)	7% (32)	0.15
Current corticosteroid	6% (21)	7% (36)	0.58
ABPM Measurements (N)	N=201	N=297
ABPM HTN	56% (112)	62% (184)	0.19
Index
Wake SBP
Mean > limit	16% (33)	15% (44)	0.70
Sleep SBP
Mean > limit	19% (38)	20% (58)	0.91
Wake DBP
Mean > limit	13% (27)	11% (32)	0.40
Sleep DBP
Mean > limit	20% (41)	22% (64)	0.82
Load
Wake SBP
>25	35% (70)	33% (97)	0.63
Sleep SBP
>25	31% (63)	39% (115)	0.11
Wake DBP
>25	31% (62)	32% (96)	0.77
Sleep DBP
>25	42% (85)	43% (129)	0.85
Casual/ABPM Hypertension Status			0.014
Normotensive	42% (84)	37% (111)
White Coat HTN	2% (5)	<1% (2)
Masked HTN	37% (74)	49% (146)
Confirmed HTN	19% (38)	13% (38)

^*Median [IQR] for continuous variables; %(n) for categorical variables.

^†Base on Wilcoxon rank sum tests for continuous variables and Fisher’s exact tests for categorical variables.

Missing data: self-reported(SR) high BP, n=21; medications, n=64.